3,272 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Purchased by New York Life Investment Management LLC

New York Life Investment Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 3,272 shares of the company’s stock, valued at approximately $666,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of INSP. McGlone Suttner Wealth Management Inc. bought a new position in shares of Inspire Medical Systems in the fourth quarter worth $27,000. NBC Securities Inc. bought a new position in Inspire Medical Systems in the 3rd quarter valued at about $34,000. RiverPark Advisors LLC bought a new position in Inspire Medical Systems in the 3rd quarter valued at about $44,000. Headinvest LLC acquired a new position in Inspire Medical Systems during the 3rd quarter valued at about $48,000. Finally, International Assets Investment Management LLC bought a new stake in shares of Inspire Medical Systems during the 4th quarter worth about $166,000. 94.91% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on INSP shares. Piper Sandler increased their price objective on shares of Inspire Medical Systems from $250.00 to $255.00 and gave the company an “overweight” rating in a report on Wednesday. KeyCorp began coverage on Inspire Medical Systems in a research note on Tuesday, February 6th. They set an “overweight” rating and a $278.00 price target for the company. Morgan Stanley began coverage on Inspire Medical Systems in a research note on Tuesday, March 19th. They issued an “overweight” rating and a $250.00 price objective on the stock. Jefferies Financial Group initiated coverage on Inspire Medical Systems in a research note on Friday, January 19th. They set a “buy” rating and a $245.00 target price for the company. Finally, Bank of America lowered Inspire Medical Systems from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $265.00 to $225.00 in a report on Wednesday. Five research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $256.53.

Inspire Medical Systems Trading Down 33.0 %

INSP stock opened at $164.47 on Thursday. Inspire Medical Systems, Inc. has a one year low of $123.27 and a one year high of $330.00. The firm has a 50-day moving average of $215.68 and a two-hundred day moving average of $190.38. The firm has a market capitalization of $4.98 billion, a PE ratio of -222.26 and a beta of 1.35.

Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings results on Tuesday, May 7th. The company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.63) by $0.29. Inspire Medical Systems had a negative net margin of 3.39% and a negative return on equity of 3.93%. The business had revenue of $164.01 million during the quarter, compared to the consensus estimate of $161.41 million. During the same quarter in the prior year, the firm earned ($0.53) EPS. The firm’s quarterly revenue was up 28.2% on a year-over-year basis. On average, equities research analysts anticipate that Inspire Medical Systems, Inc. will post -0.35 earnings per share for the current year.

Insider Transactions at Inspire Medical Systems

In related news, insider Randy Ban sold 3,060 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $182.01, for a total transaction of $556,950.60. Following the transaction, the insider now directly owns 3,029 shares of the company’s stock, valued at $551,308.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Randy Ban sold 3,060 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $182.01, for a total transaction of $556,950.60. Following the completion of the sale, the insider now directly owns 3,029 shares in the company, valued at $551,308.29. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Jerry C. Griffin sold 554 shares of the company’s stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $198.05, for a total transaction of $109,719.70. Following the completion of the transaction, the director now owns 9,744 shares in the company, valued at approximately $1,929,799.20. The disclosure for this sale can be found here. Insiders sold a total of 76,371 shares of company stock valued at $15,664,278 over the last quarter. Company insiders own 4.10% of the company’s stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.